DCFPyl PET/CT for Prostate Cancer
Release Date:
Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner. 18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.
DCFPyl PET/CT for Prostate Cancer